Vertanical launches medical cannabis Exilby in Europe
medical cannabis Exilby launches in Germany and Austria after EU approval for chronic low back pain. FDA Breakthrough granted; US Phase 3 trial of 810
Cannabis news, weed news, marijuana news
medical cannabis Exilby launches in Germany and Austria after EU approval for chronic low back pain. FDA Breakthrough granted; US Phase 3 trial of 810
VERTANICAL’s VER-01 cannabis extract with 2.5 mg THC gains FDA Breakthrough after Phase 3 showed greater pain reduction than opioids. Company announced.